$999.00

Quantity: ~1M viable cells
CIRM Line ID: CW50065
Disease: Healthy Donor
Gender: Female
Sampled age: 74
Ethinicity: Caucasian, not Latino

SKU: EXGS-QNGSVF-CW50065-1M Categories: , , Tag:

Description

Quantity: ~1M viable cells
CIRM Line ID: CW50065
Disease: Healthy Donor
Gender: Female
Sampled age: 74
Race: Caucasian, not Latino

Donor data

Demographic (source: CIRM) Description CONTROL: NO COGNITIVE DECLINE (BASED ON COGNITIVE ASSESSMENT) | CONTROL: NON-DIABETIC WITHOUT AMD/DR/POAG (SELF-REPORTED) | CHRONIC LUNG DISEASE (SELF-REPORTED): COPD/EMPHYSEMA
Affected Status No
Product iPSC
Source PBMC
Sex Female
Age at Sampling 74 YR
Race Caucasian
Ethnicity Not Hispanic or Latino
Publications Cited 0
dbGap No
Biopsy Source Blood
Collection Alzheimer’s Disease,Blinding Eye Diseases,Control,Lung Diseases
Remarks Additional Clone Available please contact�cirm@coriell.org
Cell Type Stem Cell
Tissue Type Induced pluripotent stem cell
Transformant Episomal
Species sapiens
Common Name human
Detailed Clinical Data false
Clinical data (source: CIRM) CognitiveSharedControl CognitiveSharedControl
History_of_significant_memory_changes_in_the_past_ No
History_of_major_depression_or_psychiatric_illness No
History_of_seizures_alcohol_or_drug_abuse No
Montreal_Cognitive_Assessment_(MOCA)_score_>_25/30 Yes
Parent_or_sibling_with_Alzheimers_Disease_with_ons No
OphthalmicSharedControl OphthalmicSharedControl
Glaucoma No
Age-Related_Macular_Degeneration No
Diabetic No
Diabetic_retinopathy No
Family_history_of_eye_diseases Don’t know
PulmonarySharedControl PulmonarySharedControl
Smoking_Status Former
Form_of_Tobacco Cigarettes
Cigarettes_Average_smoked_per_day_quantity 15
Cigarettes_Average_smoked_per_day_units Cigarettes
Age_Started 21
Age_Quit 55
History_of_chronic_lung_disease Yes
Chronic??lung_disease(s)_present COPD/Emphysema
Experienced_a_cough_at_least_4_days_a_week_for_at_ Yes
Experienced_breathlessness_that_limits_ability_to_ Vigorous activity (hiking, jogging, heavy lifting, etc)
Used_or_been_prescribed_oxygen No
Had_a_transplant_(bone_marrow_peripheral_stem_cell No
Active_cancer_or_cancer_diagnosis_in_the_past_2_ye No
Family_history_of_pulmonary_fibrosis No
  • Users do not need any additional license for the use of these differentiated cells even when cells are used for high throughput screening or drug discovery.
  • All donor consents include statements on the following:
    • Testing the cells’ DNA (this is referred to as the cell’s genetic code or sequence) and making the information known to other researchers
    • Changing some of the genetic code or sequence within these cells
    • Using cells to test or select drugs to treat disease
    • Transplanting cells or resulting products to humans or animals
      Distributing cells widely (nationally and internationally) for research, training or commercial medical product development
    • Future research and uses unforeseen at this time
  • Donors were screened and negative for HIV, HBV, and HCV. Donors under the age of 18 could opt out of HIV testing; all HCV-positive donors submitted skin punches, not peripheral blood, and were not screened for any infectious agents due to small volume of blood present in punches.
  • Human induced pluripotent stem cells were established by non-integrating episomal reprogramming. Reprogramming and quality control were performed by Cellular Dynamics International.

Characteristics

Please refer this page for some characteristics data.

Documents

Protocol

SDS

Others